Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial

Front Med (Lausanne). 2022 Oct 10:9:1048395. doi: 10.3389/fmed.2022.1048395. eCollection 2022.

¹ Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
² Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
³ Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Abstract

[This corrects the article DOI: 10.3389/fmed.2022.936126.].

Keywords: COVID-19; COVID-19 vaccination; heterologous vaccination; kidney transplantation; third vaccination.